International Journal of Bioinformatics and Computational Biology

ISSN: 2583-9977

Editors Overview

ijbcb maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Open Access
Special Issue
Topic

Drug designing by computational technology

Abstract Submission Deadline : November 30, 2023

Manuscript Submission Deadline : December 25, 2023

Special Issue Description

Computer-Aided Drug Design plan point manages the use of computer equipment and programming to give solutions at each phase of drug discovery. There have been various advances in the improvement of computational and statistical strategies and utilizations of large information and computer-based intelligence procedures for computer-aided drug design (CADD). Drug design is an expensive and relentless cycle of thinking about the natural complexity of infections. To design and foster another medication, CADD can be utilized to apply state-of-the-art procedures to different limits in the medication configuration field successfully and proficiently. Information pre-handling draws near, which cleans the crude information for steady and reproducible uses of enormous information, and computer-based intelligence techniques are presented. The sub-atomic docking strategies give atomic-level data regarding the interaction between drugs and macromolecules. The quantum restorative science strategies help in assessing electronic construction and give numerous insights about the substance and biogeochemical cycles related to drugs. The molecular elements techniques help model the induced fit impacts of medication macromolecule complexes. The virtual screening exertion is correlative to numerous preclinical screening endeavors being completed on lead compounds. Man-made reasoning techniques are entering the space of drug discovery incredibly by giving numerous inventive instruments. There is a colossal prerequisite in the utilization of these pharmacy informatics procedures at each phase of drug discovery. This remembers the endeavors for druggable objective recognizable proof, target approval, target 3D construction expectation, restorative science, normal item science, pharmacology (in vitro as well as in vivo), pharmaceutics, plans, drug delivery, drug disposition, preclinical preliminaries, clinical preliminaries also to concentrate on the medication patient reaction after the release. Understanding and analyzing biological, synthetic, or drug models of biomedical substances connected with drug configuration will give gainful data in the biomedical large information period.

Keywords

Computer-Aided Drug Design , Biochemical , Statistical Strategies , Pharmacology , Macromolecule Complexes

Manuscript Submission information

Manuscripts should be submitted online via the manuscript Engine. Once you register on APID, click here to go to the submission form. Manuscripts can be submitted until the deadline.
All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a Double-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Instructions for Authors page.

Participating journals: